Science 1997-04-18

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.

F M Platt, G R Neises, G Reinkensmeier, M J Townsend, V H Perry, R L Proia, B Winchester, R A Dwek, T D Butters

Index: Science 276 , 428, (1997)

Full Text: HTML

Abstract

The glycosphingolipid (GSL) lysosomal storage diseases result from the inheritance of defects in the genes encoding the enzymes required for catabolism of GSLs within lysosomes. A strategy for the treatment of these diseases, based on an inhibitor of GSL biosynthesis N-butyldeoxynojirimycin, was evaluated in a mouse model of Tay-Sachs disease. When Tay-Sachs mice were treated with N-butyldeoxynojirimycin, the accumulation of GM2 in the brain was prevented, with the number of storage neurons and the quantity of ganglioside stored per cell markedly reduced. Thus, limiting the biosynthesis of the substrate (GM2) for the defective enzyme (beta-hexosaminidase A) prevents GSL accumulation and the neuropathology associated with its lysosomal storage.

Related Compounds

  • miglustat

Related Articles:

Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

2009-10-01

[Antimicrob. Agents Chemother. 53(10) , 4311-9, (2009)]

Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses.

2014-06-01

[Antimicrob. Agents Chemother. 58(6) , 3206-16, (2014)]

Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.

2014-11-01

[J. Virol. 88(21) , 12276-95, (2014)]

Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.

2014-09-01

[J. Pharmacol. Exp. Ther. 350(3) , 624-34, (2014)]

CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings.

2015-02-01

[Mol. Genet. Metab. 114(2) , 233-41, (2015)]

More Articles...